Publicaciones en colaboración con investigadores/as de Hospital de Clínicas de Porto Alegre (1)

2015

  1. A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: The GAMMA trial

    Annals of Oncology, Vol. 26, Núm. 5, pp. 921-927